Geoffrey S. Ginsburg
Founding Director and Professor of Medicine, Patho
Infectious Diseases
Alere
Sri Lanka
Biography
Dr. Ginsburg joined Alere’s Board in July 2015. Dr. Ginsburg has served as the founding director for the Center for Applied Genomics & Precision Medicine at the Duke University Medical Center since July 2014 and is also a professor of Medicine (since September 2000), Pathology (since September 2004) and Biomedical Engineering (since September 2013) at Duke University. In addition to his current positions at Duke University, Dr. Ginsburg also serves as an expert panel member for Genome Canada; as a member of the Board of External Experts for the National Heart, Lung and Blood Institute; as Co-Chair of the Institute of Medicine’s Roundtable on Genome-Based Research to Human Health; as a member of the advisory council for the National Center for Accelerating Translational Science; as co-Chair of the Cures Acceleration Network; co-chair of the Global Genomic Medicine Collaborative; and as a member of the World Economics Forum’s Global Agenda Council on the Future of the Health Sector. Dr. Ginsburg worked at Millennium Pharmaceuticals, Inc. from 1997 to 2004, serving as senior program director for cardiovascular diseases and later as Vice President of Molecular and Personalized Medicine, where he was responsible for developing pharmacogenomics and biomarker strategies for therapeutics. Dr. Ginsburg brings to our Board a wealth of applied science expertise and experience in genomics, molecular diagnostics and personalized medicine.
Research Interest
Dr. Ginsburg joined Alere’s Board in July 2015. Dr. Ginsburg has served as the founding director for the Center for Applied Genomics & Precision Medicine at the Duke University Medical Center since July 2014 and is also a professor of Medicine (since September 2000), Pathology (since September 2004) and Biomedical Engineering (since September 2013) at Duke University. In addition to his current positions at Duke University, Dr. Ginsburg also serves as an expert panel member for Genome Canada; as a member of the Board of External Experts for the National Heart, Lung and Blood Institute; as Co-Chair of the Institute of Medicine’s Roundtable on Genome-Based Research to Human Health; as a member of the advisory council for the National Center for Accelerating Translational Science; as co-Chair of the Cures Acceleration Network; co-chair of the Global Genomic Medicine Collaborative; and as a member of the World Economics Forum’s Global Agenda Council on the Future of the Health Sector. Dr. Ginsburg worked at Millennium Pharmaceuticals, Inc. from 1997 to 2004, serving as senior program director for cardiovascular diseases and later as Vice President of Molecular and Personalized Medicine, where he was responsible for developing pharmacogenomics and biomarker strategies for therapeutics. Dr. Ginsburg brings to our Board a wealth of applied science expertise and experience in genomics, molecular diagnostics and personalized medicine.
